According to Vaxart's latest financial reports the company has $57.8 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $57.8 M | -47.73% |
2022-12-31 | $0.11 B | -41.02% |
2021-12-31 | $0.18 B | 51.97% |
2020-12-31 | $0.12 B | 852.78% |
2019-12-31 | $12.95 M | 15.25% |
2018-12-31 | $11.23 M | |
2017-06-30 | $18.7 M | -59.52% |
2016-06-30 | $46.2 M | -33.53% |
2015-06-30 | $69.5 M | -20.02% |
2014-06-30 | $86.9 M | 27.79% |
2013-06-30 | $68 M | |
2011-12-31 | $58.87 M | -2.81% |
2010-12-31 | $60.57 M | -37.82% |
2009-12-31 | $97.4 M | -19.75% |
2008-12-31 | $0.12 B | -17.16% |
2007-12-31 | $0.14 B | 31.55% |
2006-12-31 | $0.11 B | -31.17% |
2005-12-31 | $0.16 B | -43.08% |
2004-12-31 | $0.28 B | -10.96% |
2003-12-31 | $0.31 B | 68.92% |
2002-12-31 | $0.18 B | 0.97% |
2001-12-31 | $0.18 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.88 M | -104.98% | Bahamas |
NRC Health
NRC | $48.95 M | -15.31% | ๐บ๐ธ USA |